Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.
Pooja Gopal PoojariSohil KhanSonia ShenoySahana ShettyKeshava PaiLeelavathi D AcharyaSwarnali BoseGirish ThungaPublished in: PloS one (2023)
This meta-synthesis highlights key barriers from the perspectives of patients and healthcare professionals regarding the metabolic monitoring of SGAs. These barriers and suggested remedial strategies are important to pilot in the clinical setting and to assess the impact of the implementation of such strategies as a component of pharmacovigilance to promote the quality use of SGAs as well as to prevent and/or manage SGAs-induced metabolic syndrome in severe and complex mental health disorders.
Keyphrases
- mental health
- end stage renal disease
- mental illness
- metabolic syndrome
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- emergency department
- primary care
- prognostic factors
- healthcare
- oxidative stress
- insulin resistance
- type diabetes
- uric acid
- early onset
- endothelial cells
- clinical trial
- high glucose
- cardiovascular risk factors
- patient reported
- double blind